Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
31.43
-0.85 (-2.63%)
Jan 17, 2025, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for IONS stock have an average target of 62, with a low estimate of 37 and a high estimate of 77. The average target predicts an increase of 97.26% from the current stock price of 31.43.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IONS stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Hold | 6 | 6 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 18 | 18 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $70 | Buy | Reiterates | $70 | +122.72% | Jan 15, 2025 |
| Needham | Needham | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +90.90% | Dec 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $65 → $62 | Buy | Maintains | $65 → $62 | +97.26% | Nov 14, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $82 → $77 | Buy | Maintains | $82 → $77 | +144.99% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +90.90% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
630.96M
from 787.65M
Decreased by -19.89%
Revenue Next Year
699.39M
from 630.96M
Increased by 10.85%
EPS This Year
-3.49
from -2.56
EPS Next Year
-3.69
from -3.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 706.2M | 1.0B | 1.6B | |||
| Avg | 631.0M | 699.4M | 955.1M | |||
| Low | 584.1M | 423.8M | 674.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -10.3% | 62.0% | 125.1% | |||
| Avg | -19.9% | 10.8% | 36.6% | |||
| Low | -25.8% | -32.8% | -3.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.19 | -2.25 | -1.38 | |||
| Avg | -3.49 | -3.69 | -2.83 | |||
| Low | -3.66 | -5.07 | -4.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.